Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

May 4, 2004

29777_dirs_2004-05-04_37d5e273-2684-4008-95cf-da81982dddf4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-30

Reporting Person: BEGLEY CHRISTOPHER B (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-04-30 Common Shares F 3506 $41.465 Disposed 240618 Direct
2004-04-30 Common Shares F 10543 $41.465 Disposed 230075 Direct
2004-04-30 Common Shares F 7591 $41.465 Disposed 222484 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 14009 Indirect

Footnotes

F1: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2004.